[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertise Here
June 7, 2010
Volume 88, Number 23
p. 11
Article Appeared Online June 4, 2010

Drug Prices

Companies to pull products from Greek market after price cuts

Lisa M. Jarvis

  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

Amid significant drug-pricing pressure in Europe, pharmaceutical companies are taking a hard line with countries that they say have taken price cuts too far.

After Greece unveiled plans to cut drug prices by 25% on average, Novo Nordisk said it would withdraw its most modern insulin products from that country over the next three months. Meanwhile, fellow Danish drug firm Leo Pharma is pulling its dermatology and critical care products from Greece as well. Merck KGaA could be next to go, according to a research report by the investment bank Citigroup.

Withdrawing vital medications might seem like an extreme decision, but Leo Pharma points out that Greek drug prices, already the lowest in Europe, are also the reference point for prices in several other European countries.

Leo Pharma is in talks with Greek authorities to come up with an alternative to pulling out of the country. For now, the company says it sees “no other solution” than to withdraw some of its products from the Greek market. “A price reduction on our products of up to 37% will have severe consequences on our total business,” the firm says.

Many European countries are struggling under debt and aiming to reduce health care costs by lowering drug prices. Last week, the French government said it would cut $120 million from its health care budget by trimming drug prices, and Italy said it was snipping generic drug prices by 12.5% and would limit reimbursement on branded drugs. Spain just passed a bill reducing drug prices by 7.5%, except for drugs for rare diseases, which will be trimmed by 4.0%, according to the Citigroup report.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!